17 October 2024

Clinical Neurology TGA

TGA rejects lecanemab for Alzheimer’s

30 September 2024

The Back Page

Donanemab don’t pass the sniff test

24 September 2024

Aged Care Clinical Dementia

Coming up: MCI, biomarkers and medications

18 July 2023

Aged Care Pharmaceuticals

New Alzheimer drug may pump demand for screening

23 November 2022

Genetics Neurology

ApoE4 test offers ‘false worry, false comfort’

1 November 2022

COVID-19 Neurology

Covid may trigger Parkinson’s, Alzheimer’s

2 August 2022

Neurology Research

Alzheimer’s research fraud claims: what do they mean?

7 March 2022

Clinical Neurology Pharmaceuticals

Alzheimer’s drug ‘unproven, costly, risky’

12 November 2021

Clinical Neurology

Alzheimer’s: addressing the metabolic abnormality

10 November 2021

Clinical Neurology

Alzheimer’s: an update on diagnosis and management

16 July 2021

Clinical Drugs Neurology

FDA calls watchdog on itself over aducanumab

8 July 2021

Clinical Neurology

Doubts cloud costly Alzheimer’s drug

25 June 2020

Gastro Mental Health Research

Dementia risk doubles for people with IBD

5 June 2020

Clinical Mental Health Neurology Research

A blood test for Alzheimer’s – is it that simple?